文献速递肾癌与肾肿瘤

肾移植术后输尿管狭窄治疗的新技术

A new technique for the treatment of ureteric stricture after kidney transplantation.
PubMed 文献 · BJU Int · 2024-06-04

该前瞻性研究纳入68例肾移植术后输尿管狭窄患者,采用Allium®金属输尿管支架(AMUS)内镜治疗,随访1年总体成功率为90%(61/68),术后血肌酐、尿素氮及肾积水体积下降,估算肾小球滤过率升高,并发症包括血尿(18%)等,作者认为该技术短期安全有效。

要点

  • 肾移植术后输尿管狭窄行AMUS内镜治疗1年总体成功率为90%(61/68)。
  • 术后1个月血肌酐(105.5 vs 90.4 mol/L)、尿素氮(6.6 vs 5.4 mmol/L)及肾积水体积(64.4 vs 43.9 mL)下降,估算肾小球滤过率由49.5升至64.4 mL/min/1.73 m2。
  • 并发症包括血尿(18%)、疼痛(10%)、尿路感染(7.4%)及下尿路症状(7.4%),支架移位、闭塞和结壳发生率分别为10%、2.9%和1.5%。

核心结论

  • 作者认为系统性AMUS内镜治疗对肾移植术后输尿管狭窄在短期随访中安全有效,为移植后狭窄提供了一种新选择。

研究设计与样本

  • 前瞻性研究,纳入2019年1月至2022年3月期间因肾移植术后输尿管狭窄接受AMUS内镜治疗的68例患者。

主要发现

  • 随访1年总体成功率为90%(61/68)。
  • 术后1个月血肌酐(105.5 vs 90.4 mol/L)、尿素氮(6.6 vs 5.4 mmol/L)及肾积水体积(64.4 vs 43.9 mL)下降,估算肾小球滤过率由49.5升至64.4 mL/min/1.73 m2。
  • 术后1年随访结果与术后1个月相似。
  • 并发症包括血尿(18%)、疼痛(10%)、尿路感染(7.4%)及下尿路症状(7.4%),支架移位、闭塞和结壳发生率分别为10%、2.9%和1.5%。

局限性

  • 作者结论限定于短期随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the safety and effectiveness of endoscopic treatments with Allium® metal ureteric stent (AMUS) for ureteric strictures after kidney transplantation (KT). PATIENTS AND METHODS: In a prospective manner, we gathered clinical data from 68 patients who underwent endoscopic treatments with AMUS for ureteric strictures after KT between January 2019 and March 2022. The definition of surgical success was the unobstructed drainage of the AMUS, or in cases where there was AMUS migration, occlusion or encrustation and subsequently removed, there is no worsening of renal hydronephrosis in the patient during the follow-up period. RESULTS: Based on the specific circumstances of the ureteric strictures, three distinct types of surgery were selected for treatment. The overall success rate of endoscopic treatments for ureteric strictures following KT was 90% (61/68) during a follow-up period of 1 year. Surgical complications included haematuria (18%), pain (10%), urinary tract infections (7.4%), and lower urinary tract symptoms (7.4%). The incidences of stent migration, occlusion, and encrustation were 10%, 2.9%, and 1.5%, respectively. Postoperatively, significant improvements were observed in various parameters. At 1 month after surgery, there was a notable decrease in blood creatinine levels (105.5 vs 90.4 mol/L), urea nitrogen levels (6.6 vs 5.4 mmol/L), and hydronephrosis volume (64.4 vs 43.9 mL). Additionally, the serum estimated glomerular filtration rate increased from 49.5 to 64.4 mL/min/1.73 m2. The follow-up results of patients at 1 year after surgery were similar to those observed at 1 month after surgery. CONCLUSIONS: Systemic endoscopic treatments with AMUS were found to be safe and effective for ureteric strictures after KT with short-term follow-ups. This technique offers a novel option for the treatment of post-KT strictures.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Gao X, Wang W, Li F, et al. A new technique for the treatment of ureteric stricture after kidney transplantation. BJU Int. 2024. PMID: 38837647. doi:10.1111/bju.16428

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。